Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -6.33% is 43% above its 5-year average of -11.04%, near the high end of its 5-year range (-25.27%–1.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.85% above its 12-month average of -6.58%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -6.33%.
RETURN ON INVESTED CAPITAL (ROIC)
-6.33%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-6.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-5.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-11.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.85%
CURRENT VS 3Y AVG
-7.78%
CURRENT VS 5Y AVG
+42.72%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+82.25%
vs the sector median at left
Castle Biosciences, Inc.
Market Cap
$1.02B
Return on Invested Capital (ROIC)
-6.33%
TTM Avg
-6.58%
3Y Avg
-5.87%
5Y Avg
-11.04%
Market Cap
$1.02B
Return on Invested Capital (ROIC)
-15.15%
TTM Avg
-12.74%
3Y Avg
-16.16%
5Y Avg
-18.46%
Market Cap
$1.03B
Return on Invested Capital (ROIC)
0.86%
TTM Avg
2.66%
3Y Avg
2.26%
5Y Avg
2.26%
Market Cap
$1.01B
Return on Invested Capital (ROIC)
-53.36%
TTM Avg
-19.72%
3Y Avg
-15.42%
5Y Avg
-34.93%
Market Cap
$1.04B
Return on Invested Capital (ROIC)
20.01%
TTM Avg
1.42%
3Y Avg
2.77%
5Y Avg
3.34%
Market Cap
$998.69M
Return on Invested Capital (ROIC)
-68.64%
TTM Avg
-46.08%
3Y Avg
-28.67%
5Y Avg
-26.80%
Market Cap
$996.65M
Return on Invested Capital (ROIC)
-27.51%
TTM Avg
-21.69%
3Y Avg
-25.73%
5Y Avg
-26.71%
Market Cap
$992.14M
Return on Invested Capital (ROIC)
-32.24%
TTM Avg
-91.06%
3Y Avg
-69.60%
5Y Avg
-62.21%
Market Cap
$1.05B
Return on Invested Capital (ROIC)
-7.32%
TTM Avg
-21.18%
3Y Avg
-91.27%
5Y Avg
-61.58%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Castle Biosciences, Inc. (CSTL) | $1.02B | -6.33% | -6.58% | -5.87% | -11.04% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | -15.15% | -12.74% | -16.16% | -18.46% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.03B | 0.86% | 2.66% | 2.26% | 2.26% |
| Immatics N.V. (IMTX)vs › | $1.01B | -53.36% | -19.72% | -15.42% | -34.93% |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | 20.01% | 1.42% | 2.77% | 3.34% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | -68.64% | -46.08% | -28.67% | -26.80% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $996.65M | -27.51% | -21.69% | -25.73% | -26.71% |
| Vor Biopharma Inc. (VOR)vs › | $992.14M | -32.24% | -91.06% | -69.60% | -62.21% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -7.32% | -21.18% | -91.27% | -61.58% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $982.46M | -28.14% | -132.46% | -76.17% | -76.17% |
ROIC
-6.3%
ROE
-4.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -6.33% |
| 2026-03-31 | -6.65% |
| 2025-12-31 | -8.39% |
| 2025-09-30 | -6.88% |
| 2025-06-30 | -4.65% |
| 2025-03-31 | -2.96% |
| 2024-12-31 | 1.52% |
| 2024-09-30 | -0.12% |
| 2024-06-30 | -3.52% |
| 2024-03-31 | -9.83% |
| 2023-12-31 | -16.76% |
| 2023-09-30 | -21.30% |
| 2023-06-30 | -24.78% |
| 2023-03-31 | -25.27% |
| 2022-12-31 | -22.68% |
| 2022-09-30 | -20.10% |
| 2022-06-30 | -17.61% |
| 2022-03-31 | -14.90% |
| 2021-12-31 | -9.16% |
| 2021-09-30 | -6.77% |
| 2021-06-30 | -4.80% |
| 2021-03-31 | -2.83% |
| 2020-12-31 | -1.56% |
| 2020-09-30 | -0.47% |
| 2020-06-30 | 2.23% |
| 2020-03-31 | 4.21% |
| 2019-12-31 | 3.65% |
| 2019-09-30 | 4.86% |
| 2019-06-30 | 8.20% |
| 2019-03-31 | -3.66% |
| 2018-12-31 | -24.48% |
